Reimbursement for Continuous Glucose Monitoring
نویسندگان
چکیده
منابع مشابه
Reimbursement for new diabetes technologies: continuous glucose monitoring (CGM).
Abbreviations: (AACE)American Association of Clinical Endocrinologists, (ADA) American Diabetes Association, (AMA) American Medical Association, (CGM) continuous glucose monitoring, (CMS) Centers for Medicare and Medicaid Services, (CPT) current procedural terminology, (DMEPOS) durable medical equipment, prosthetics, orthotics, and supplies, (E/M) evaluation and management, (HCPCS) Healthcare C...
متن کاملReimbursement for continuous glucose monitoring: a European view.
Different systems for continuous glucose monitoring (CGM) are available on the European market. There is no unlimited reimbursement for CGM use in any European country, but in some countries, reimbursement exists for certain clinical indications. The aim of this commentary is to describe the different reimbursement situations across Europe for this innovative but costly technology, as a prelude...
متن کاملA look at the current reimbursement environment for continuous glucose monitoring (CGM): understanding the fundamentals.
As reimbursement continues to decline for diabetes management technologies and practice overhead continues to rise, it is becoming increasingly important to understand the current reimbursement environment for new technological innovations in diabetes care. The current environment demands a strong partnership among providers, key stakeholder groups, and industry to advocate for favorable coding...
متن کاملContinuous glucose monitoring system for congenital hyperinsulinemia.
Blood glucose monitoring is a way of testing the concentration of glucose in the blood. The most recent advance is the development of continuous glucose monitoring system (CGMS) which gives 24 hour trend of blood sugar levels thus helping both the patient and the physician in achieving better glycemic control. CGMS in pediatric population is generally used for those on insulin pumps and those w...
متن کاملContinuous glucose monitoring and pumps.
BACKGROUND While multiple daily insulin injections remains the state-of-the-art treatment for type 1 diabetes, continuous subcutaneous insulin infusion (CSII) has become increasingly popular in recent years. Up to 40% of people with type 1 diabetes in younger age groups are now using CSII. Very recently, continuous glucose monitoring (CGM) has been developed. This technology now has proven bene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Technology & Therapeutics
سال: 2016
ISSN: 1520-9156,1557-8593
DOI: 10.1089/dia.2015.0296